Background Cellular prion-related protein (PrPc) is a cell-surface protein that is ubiquitously expressed in the human body. The multifunctionality of PrPc, and presence of an exposed cationic and heparin-binding N-terminus, a feature characterizing many antimicrobial peptides, made us hypotesize that PrPc could exert antimicrobial activity. Methodology and Principal Findings Intact recombinant PrP exerted antibacterial and antifungal effects at normal and low pH. Studies employing recombinant PrP and N- and C-terminally truncated variants, as well as overlapping peptide 20mers, demonstrated that the antimicrobial activity is mediated by the unstructured N-terminal part of the protein. Synthetic peptides of the N-terminus of PrP killed the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa, and the Gram-positive Bacillus subtilis and Staphylococcus aureus, as well as the fungus Candida parapsilosis. Fluorescence studies of peptide-treated bacteria, paired with analysis of peptide effects on liposomes, showed that the peptides exerted membrane-breaking effects similar to those seen after treatment with the “classical” human antimicrobial peptide LL-37. In contrast to LL-37, however, no marked helix induction was detected for the PrP-derived peptides in presence of negatively charged (bacteria-mimicking) liposomes. PrP furthermore showed an inducible expression during wounding of human skin ex vivo and in vivo, as well as stimulation of keratinocytes with TGF-α in vitro. Conclusions The demonstration of an antimicrobial activity of PrP, localisation of its activity to the N-terminal and heparin-binding region, combined with results showing an increased expression of PrP during wounding, indicate that PrPs could have a previously undisclosed role in host defense.
Zelezetsky I, Tossi A (2006) Alpha-helical antimicrobial peptides–using a sequence template to guide structure-activity relationship studies. Biochim Biophys Acta 1758: 1436–1449.
[3]
Tossi A, Sandri L (2002) Molecular diversity in gene-encoded, cationic antimicrobial polypeptides. Curr Pharm Des 8: 743–761.
[4]
Powers JP, Hancock RE (2003) The relationship between peptide structure and antibacterial activity. Peptides 24: 1681–1691.
[5]
Bulet P, Stocklin R, Menin L (2004) Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev 198: 169–184.
[6]
Durr UH, Sudheendra US, Ramamoorthy A (2006) LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 1758: 1408–1425.
[7]
Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238–250.
[8]
Lohner K, Blondelle SE (2005) Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. Comb Chem High Throughput Screen 8: 241–256.
[9]
Beisswenger C, Bals R (2005) Functions of antimicrobial peptides in host defense and immunity. Curr Protein Pept Sci 6: 255–264.
[10]
Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ (2004) Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 22: 181–215.
[11]
Elsbach P (2003) What is the real role of antimicrobial polypeptides that can mediate several other inflammatory responses? J Clin Invest 111: 1643–1645.
[12]
Nordahl EA, Rydeng？rd V, M？rgelin M, Schmidtchen A (2005) Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem 280: 34832–34839.
[13]
Nordahl EA, Rydeng？rd V, Nyberg P, Nitsche DP, M？rgelin M, et al. (2004) Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A 101: 16879–16884.
[14]
Pasupuleti M, Walse B, Nordahl EA, Morgelin M, Malmsten M, et al. (2007) Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans. J Biol Chem 282: 2520–2528.
[15]
Frick IM, Akesson P, Herwald H, Morgelin M, Malmsten M, et al. (2006) The contact system–a novel branch of innate immunity generating antibacterial peptides. Embo J 25: 5569–5578.
[16]
Andersson E, Rydeng？rd V, Sonesson A, M？rgelin M, Bj？rck L, et al. (2004) Antimicrobial activities of heparin-binding peptides. Eur J Biochem 271: 1219–1226.
[17]
Ringstad L, Schmidtchen A, Malmsten M (2006) Effect of Peptide Length on the Interaction between Consensus Peptides and DOPC/DOPA Bilayers. Langmuir 22: 5042–5050.
[18]
Pammer J, Weninger W, Tschachler E (1998) Human keratinocytes express cellular prion-related protein in vitro and during inflammatory skin diseases. Am J Pathol 153: 1353–1358.
[19]
Zhang CC, Steele AD, Lindquist S, Lodish HF (2006) Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc Natl Acad Sci U S A 103: 2184–2189.
[20]
Konturek PC, Bazela K, Kukharskyy V, Bauer M, Hahn EG, et al. (2005) Helicobacter pylori upregulates prion protein expression in gastric mucosa: a possible link to prion disease. World J Gastroenterol 11: 7651–7656.
[21]
Zomosa-Signoret V, Arnaud JD, Fontes P, Alvarez-Martinez MT, Liautard JP (2008) Physiological role of the cellular prion protein. Vet Res 39: 9.
[22]
Pauly PC, Harris DA (1998) Copper stimulates endocytosis of the prion protein. J Biol Chem 273: 33107–33110.
[23]
Brown DR, Besinger A (1998) Prion protein expression and superoxide dismutase activity. Biochem J 334 ( Pt 2): 423–429.
[24]
Pan T, Wong BS, Liu T, Li R, Petersen RB, et al. (2002) Cell-surface prion protein interacts with glycosaminoglycans. Biochem J 368: 81–90.
[25]
McBride SM (2005) Prion protein: a pattern recognition receptor for viral components and uric acid responsible for the induction of innate and adaptive immunity. Med Hypotheses 65: 570–577.
[26]
Morillas M, Swietnicki W, Gambetti P, Surewicz WK (1999) Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem 274: 36859–36865.
[27]
Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, et al. (2001) Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol 2: 1133–1137.
[28]
Lehrer RI, Rosenman M, Harwig SS, Jackson R, Eisenhauer P (1991) Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 137: 167–173.
[29]
Greenfield N, Fasman GD (1969) Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 8: 4108–4116.
[30]
Sjogren H, Ulvenlund S (2005) Comparison of the helix-coil transition of a titrating polypeptide in aqueous solutions and at the air-water interface. Biophys Chem 116: 11–21.
[31]
Roupe KM, Nybo M, Sjobring U, Alberius P, Schmidtchen A, et al. (2009) Injury Is a Major Inducer of Epidermal Innate Immune Responses during Wound Healing. J Invest Dermatol.
[32]
Parkinson H, Kapushesky M, Kolesnikov N, Rustici G, Shojatalab M, et al. (2009) ArrayExpress update–from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res 37: D868–872.
[33]
Stewart RS, Drisaldi B, Harris DA (2001) A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum. Mol Biol Cell 12: 881–889.
[34]
Rydeng？rd V, Nordahl EA, Schmidtchen A (2006) Zinc potentiates the antibacterial effects of histidine-rich peptides against Enterococcus faecalis. Febs J 273: 2399–2406.
[35]
Kacprzyk L, Rydengard V, Morgelin M, Davoudi M, Pasupuleti M, et al. (2007) Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions. Biochim Biophys Acta 1768: 2667–2680.
[36]
Rydengard V, Shannon O, Lundqvist K, Kacprzyk L, Chalupka A, et al. (2008) Histidine-rich glycoprotein protects from systemic Candida infection. PLoS Pathog 4: e1000116.
[37]
Rydengard V, Olsson AK, Morgelin M, Schmidtchen A (2007) Histidine-rich glycoprotein exerts antibacterial activity. Febs J 274: 377–389.
[38]
Pasupuleti M, Walse B, Svensson B, Malmsten M, Schmidtchen A (2008) Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach. Biochemistry 47: 9057–9070.
[39]
Magzoub M, Oglecka K, Pramanik A, Goran Eriksson LE, Graslund A (2005) Membrane perturbation effects of peptides derived from the N-termini of unprocessed prion proteins. Biochim Biophys Acta 1716: 126–136.
[40]
Jiang Z, Kullberg BJ, van der Lee H, Vasil AI, Hale JD, et al. (2008) Effects of Hydrophobicity on the Antifungal Activity of alpha-Helical Antimicrobial Peptides. Chem Biol Drug Des 72: 483–495.
[41]
Ganz T (2001) Antimicrobial proteins and peptides in host defense. Semin Respir Infect 16: 4–10.
[42]
Wang Y, Agerberth B, Lothgren A, Almstedt A, Johansson J (1998) Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J Biol Chem 273: 33115–33118.
[43]
Pereira HA (1995) CAP37, a neutrophil-derived multifunctional inflammatory mediator. J Leukoc Biol 57: 805–812.
[44]
Malmsten M, Davoudi M, Walse B, Rydengard V, Pasupuleti M, et al. (2007) Antimicrobial peptides derived from growth factors. Growth Factors 25: 60–70.
[45]
Nilsson M, Wasylik S, Morgelin M, Olin AI, Meijers JC, et al. (2008) The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes. Mol Microbiol 67: 482–492.
[46]
Cobb NJ, Apetri AC, Surewicz WK (2008) Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain. J Biol Chem 283: 34704–34711.
[47]
Ringstad L, Kacprzyk L, Schmidtchen A, Malmsten M (2007) Effects of topology, length, and charge on the activity of a kininogen-derived peptide on lipid membranes and bacteria. Biochim Biophys Acta 1768: 715–727.
[48]
Huang HW (2006) Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta 1758: 1292–1302.
[49]
Stromstedt AA, Wessman P, Ringstad L, Edwards K, Malmsten M (2007) Effect of lipid headgroup composition on the interaction between melittin and lipid bilayers. J Colloid Interface Sci 311: 59–69.
[50]
Ramamoorthy A, Thennarasu S, Lee DK, Tan A, Maloy L (2006) Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin. Biophys J 91: 206–216.
[51]
Ringstad L, Andersson Nordahl E, Schmidtchen A, Malmsten M (2007) Composition Effect on Peptide Interaction with Lipids and Bacteria: Variants of C3a Peptide CNY21. Biophys J 92: 87–98.
[52]
Ringstad L, Protopapa E, Lindholm-Sethson B, Schmidtchen A, Nelson A, et al. (2008) An electrochemical study into the interaction between complement-derived peptides and DOPC mono- and bilayers. Langmuir 24: 208–216.
[53]
Chen FY, Lee MT, Huang HW (2003) Evidence for membrane thinning effect as the mechanism for peptide-induced pore formation. Biophys J 84: 3751–3758.
[54]
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389–395.
[55]
McMahon HE, Mange A, Nishida N, Creminon C, Casanova D, et al. (2001) Cleavage of the amino terminus of the prion protein by reactive oxygen species. J Biol Chem 276: 2286–2291.
[56]
Harris DA (2003) Trafficking, turnover and membrane topology of PrP. Br Med Bull 66: 71–85.
[57]
Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, et al. (1988) Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem 263: 7472–7477.
[58]
Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, et al. (2003) Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 74: 448–455.
